Comparative Efficacy of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Treatment Response in Atopic Dermatitis at Varying Treatment Continuance Rates. (2025). SKIN The Journal of Cutaneous Medicine, 9(1), s519. https://doi.org/10.25251/skin.9.supp.519